Medicine guide
Regkirona
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Regdanvimab
- Made by
- Celltrion Healthcare Hungary Kft.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | Celltrion Healthcare Hungary Kft. |
|---|---|
| Active substance | Regdanvimab |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J06BD06 · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2021-11-12 |
| Last updated by the regulator | 2025-04-24 |
| EMA product number | EMEA/H/C/005854 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).